Xeris Biopharma Holdings Inc (XERS)
3.05
-0.10
(-3.17%)
USD |
NASDAQ |
Nov 14, 16:00
3.05
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Total Return Level: 3.05 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 3.05 |
November 13, 2024 | 3.15 |
November 12, 2024 | 3.15 |
November 11, 2024 | 3.28 |
November 08, 2024 | 3.47 |
November 07, 2024 | 3.36 |
November 06, 2024 | 3.34 |
November 05, 2024 | 3.26 |
November 04, 2024 | 3.22 |
November 01, 2024 | 3.23 |
October 31, 2024 | 3.22 |
October 30, 2024 | 3.23 |
October 29, 2024 | 3.23 |
October 28, 2024 | 3.23 |
October 25, 2024 | 3.20 |
October 24, 2024 | 3.24 |
October 23, 2024 | 3.11 |
October 22, 2024 | 3.02 |
October 21, 2024 | 3.03 |
October 18, 2024 | 3.06 |
October 17, 2024 | 3.04 |
October 16, 2024 | 3.04 |
October 15, 2024 | 3.02 |
October 14, 2024 | 2.97 |
October 11, 2024 | 2.91 |
Date | Value |
---|---|
October 10, 2024 | 2.78 |
October 09, 2024 | 2.81 |
October 08, 2024 | 2.94 |
October 07, 2024 | 2.93 |
October 04, 2024 | 2.98 |
October 03, 2024 | 2.98 |
October 02, 2024 | 2.91 |
October 01, 2024 | 2.79 |
September 30, 2024 | 2.85 |
September 27, 2024 | 2.87 |
September 26, 2024 | 2.83 |
September 25, 2024 | 2.80 |
September 24, 2024 | 2.82 |
September 23, 2024 | 2.76 |
September 20, 2024 | 2.93 |
September 19, 2024 | 2.96 |
September 18, 2024 | 2.90 |
September 17, 2024 | 2.90 |
September 16, 2024 | 2.88 |
September 13, 2024 | 2.88 |
September 12, 2024 | 2.86 |
September 11, 2024 | 2.86 |
September 10, 2024 | 2.71 |
September 09, 2024 | 2.67 |
September 06, 2024 | 2.51 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.03
Minimum
Jan 05 2023
9.00
Maximum
Dec 10 2019
2.968
Average
2.45
Median
Sep 30 2021
Total Return Level Benchmarks
Zevra Therapeutics Inc | 9.03 |
NovaBay Pharmaceuticals Inc | 0.727 |
Palatin Technologies Inc | 1.07 |
iBio Inc | 2.15 |
Theriva Biologics Inc | 1.35 |